| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |